LA, D. S., H, K., CA, E., EV, P., KC, D., R, S., . . . M, M. (2026). Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome. Scientific reports, 16(1), . https://doi.org/10.1038/s41598-026-44380-0
Chicago Style (17th ed.) CitationLA, De Stefano, Kim H, Erickson CA, Pedapati EV, Dominick KC, Shaffer R, Wink LK, Schmitt LM, and Miyakoshi M. "Acute and Chronic Dosing of the GABA A Alpha 2,3 Selective Agonist BAER-101 Do Not Alter Behavior but May Impact Auditory-evoked EEG Responses in Adults with Fragile X Syndrome." Scientific Reports 16, no. 1 (2026). https://doi.org/10.1038/s41598-026-44380-0.
MLA (9th ed.) CitationLA, De Stefano, et al. "Acute and Chronic Dosing of the GABA A Alpha 2,3 Selective Agonist BAER-101 Do Not Alter Behavior but May Impact Auditory-evoked EEG Responses in Adults with Fragile X Syndrome." Scientific Reports, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41598-026-44380-0.
